Thermo Fisher Scientific Inc. (TMO): Price and Financial Metrics

Thermo Fisher Scientific Inc. (TMO): $608.34

0.59 (+0.10%)

POWR Rating

Component Grades














  • Sentiment is the dimension where TMO ranks best; there it ranks ahead of 92.57% of US stocks.
  • The strongest trend for TMO is in Growth, which has been heading down over the past 52 weeks.
  • TMO's current lowest rank is in the Momentum metric (where it is better than 24.12% of US stocks).

TMO Stock Summary

  • TMO has a higher market value than 99.24% of US stocks; more precisely, its current market capitalization is $239,100,335,867.
  • Thermo Fisher Scientific Inc's stock had its IPO on September 1, 1987, making it an older stock than 91.47% of US equities in our set.
  • Revenue growth over the past 12 months for Thermo Fisher Scientific Inc comes in at 45.73%, a number that bests 84.78% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to TMO, based on their financial statements, market capitalization, and price volatility, are DHR, ABT, CMCSA, KO, and NVO.
  • Visit TMO's SEC page to see the company's official filings. To visit the company's web site, go to

TMO Valuation Summary

  • In comparison to the median Healthcare stock, TMO's EV/EBIT ratio is 24.91% lower, now standing at 22.
  • TMO's EV/EBIT ratio has moved down 79.8 over the prior 243 months.
  • Over the past 243 months, TMO's price/sales ratio has gone up 3.9.

Below are key valuation metrics over time for TMO.

Stock Date P/S P/B P/E EV/EBIT
TMO 2021-08-31 5.7 5.9 25.4 22.0
TMO 2021-08-30 5.7 6.0 25.6 22.1
TMO 2021-08-27 5.6 5.9 25.1 21.7
TMO 2021-08-26 5.7 5.9 25.3 21.9
TMO 2021-08-25 5.6 5.9 25.1 21.7
TMO 2021-08-24 5.7 5.9 25.2 21.8

TMO Growth Metrics

  • Its year over year net income to common stockholders growth rate is now at 115.97%.
  • The 4 year cash and equivalents growth rate now stands at 260.55%.
  • Its 3 year price growth rate is now at 89.59%.
TMO's revenue has moved up $13,892,000,000 over the prior 30 months.

The table below shows TMO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 38,250 10,252 8,596
2021-03-31 35,894 9,911 7,924
2020-12-31 32,218 8,289 6,375
2020-09-30 28,497 6,863 4,879
2020-06-30 26,248 5,272 3,706
2020-03-31 25,647 4,680 3,669

TMO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TMO has a Quality Grade of C, ranking ahead of 64.17% of graded US stocks.
  • TMO's asset turnover comes in at 0.574 -- ranking 42nd of 75 Measuring and Control Equipment stocks.
  • PACB, PKI, and PRPO are the stocks whose asset turnover ratios are most correlated with TMO.

The table below shows TMO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-03 0.574 0.513 0.323
2021-04-03 0.551 0.515 0.302
2020-12-31 0.509 0.497 0.244
2020-09-26 0.470 0.473 0.209
2020-06-27 0.446 0.454 0.166
2020-03-28 0.443 0.443 0.174

TMO Price Target

For more insight on analysts targets of TMO, see our TMO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $586.74 Average Broker Recommendation 1.36 (Strong Buy)

TMO Stock Price Chart Interactive Chart >

Price chart for TMO

TMO Price/Volume Stats

Current price $608.34 52-week high $616.93
Prev. close $607.75 52-week low $433.52
Day low $603.86 Volume 1,049,210
Day high $611.00 Avg. volume 1,555,107
50-day MA $575.88 Dividend yield 0.17%
200-day MA $507.86 Market Cap 239.33B

Thermo Fisher Scientific Inc. (TMO) Company Bio

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues. (Source:Wikipedia)

TMO Latest News Stream

Event/Time News Detail
Loading, please wait...

TMO Latest Social Stream

Loading social stream, please wait...

View Full TMO Social Stream

Latest TMO News From Around the Web

Below are the latest news stories about Thermo Fisher Scientific Inc that investors may wish to consider to help them evaluate TMO as an investment opportunity.

Abbott's (ABT) Organic Sales Grow Amid Spike in COVID Cases

Within Nutrition, the robust year-over-year performance of Abbott's (ABT) U.S. pediatric and international adult nutrition arms drives the company in the third quarter.

Yahoo | October 25, 2021

Why Thermo Fisher (TMO) Might Surprise This Earnings Season

Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Yahoo | October 25, 2021

Three Best ESG Companies By Industry Category

What are the best ESG companies that lead their industry? We list the three high-ranking ESG stocks with the highest growth stock ratings in their business.

Yahoo | October 25, 2021

Sheaff Brock Investment Advisors LLC Reduces Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

Sheaff Brock Investment Advisors LLC trimmed its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 74.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 729 shares of the medical research companys stock after selling 2,120 shares during the period. Sheaff Brock Investment Advisors LLCs holdings []

Dakota Financial News | October 23, 2021

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Utah Retirement Systems

Utah Retirement Systems trimmed its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 74,922 shares of the medical research companys stock after selling 933 shares during the period. Utah []

Dakota Financial News | October 23, 2021

Read More 'TMO' Stories Here

TMO Price Returns

1-mo -0.24%
3-mo 15.21%
6-mo 31.13%
1-year 26.36%
3-year 166.45%
5-year 313.44%
YTD 30.82%
2020 43.72%
2019 45.55%
2018 18.21%
2017 35.03%
2016 -0.12%

TMO Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full TMO Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8683 seconds.